Incannex Healthcare Inc. Files 8-K
Ticker: IXHL · Form: 8-K · Filed: Aug 26, 2025 · CIK: 1873875
| Field | Detail |
|---|---|
| Company | Incannex Healthcare Inc. (IXHL) |
| Form Type | 8-K |
| Filed Date | Aug 26, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, routine-update
TL;DR
Incannex Healthcare filed an 8-K on Aug 26, 2025. Routine update, check for details.
AI Summary
Incannex Healthcare Inc. filed an 8-K on August 26, 2025, reporting other events and financial statements. The company, incorporated in Delaware, is based in Norwest, NSW, Australia, and operates in the Pharmaceutical Preparations sector. This filing does not detail specific transactions or financial figures but serves as a routine update.
Why It Matters
This 8-K filing indicates Incannex Healthcare Inc. is providing updates to the SEC, which could include material information relevant to investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for 'Other Events' and financial statements, without immediate indication of significant negative or positive developments.
Key Players & Entities
- Incannex Healthcare Inc. (company) — Registrant
- August 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Norwest, NSW (location) — Principal Executive Offices
- Pharmaceutical Preparations (industry) — Standard Industrial Classification
FAQ
What specific 'Other Events' are being reported by Incannex Healthcare Inc. in this 8-K filing?
The provided text does not specify the 'Other Events' being reported, only that this item is included in the filing.
When was Incannex Healthcare Inc. incorporated, and in which state?
Incannex Healthcare Inc. was incorporated in Delaware.
What is the primary business address of Incannex Healthcare Inc.?
The primary business address is Suite 105, 8 Century Circuit, Norwest, NSW 2153, Australia.
What is the SIC code for Incannex Healthcare Inc.?
The Standard Industrial Classification (SIC) code for Incannex Healthcare Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the telephone number listed for Incannex Healthcare Inc.?
The telephone number listed for Incannex Healthcare Inc. is +61 409 840 786.
Filing Stats: 441 words · 2 min read · ~1 pages · Grade level 11 · Accepted 2025-08-26 08:00:30
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq
Filing Documents
- ea0254452-8k_incannex.htm (8-K) — 26KB
- ea025445201ex99-1_incannex.htm (EX-99.1) — 22KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- ex99-1_002.jpg (GRAPHIC) — 5KB
- ex99-1_003.jpg (GRAPHIC) — 10KB
- ex99-1_004.jpg (GRAPHIC) — 30KB
- 0001213900-25-080509.txt ( ) — 288KB
- ixhl-20250826.xsd (EX-101.SCH) — 3KB
- ixhl-20250826_lab.xml (EX-101.LAB) — 33KB
- ixhl-20250826_pre.xml (EX-101.PRE) — 22KB
- ea0254452-8k_incannex_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On August 26, 2025, Incannex Healthcare Inc. Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder. Further information is included in the press release attached as Exhibit 99.1 hereto, which is incorporated by reference into this Item 8.01.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Incannex Healthcare Inc., dated August 26, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Incannex Healthcare Inc. Date: August 26, 2025 /s/ Joel Latham Name: Joel Latham Title: Chief Executive Officer and President 2